55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Completes Acquisition of KalVista Pharmaceuticals
To Acquire Pharmaceuticals, Expanding its Global Rare Disease Portfolio
Financial Results, Press Release
Investor Presentation
Provides Operational Update and Reports Third Quarter Financial Results
Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer
Announces Appointment of Bethany L. Sensenig to Board of Directors
Material Contracts, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Other Events
Q3
Annual Report Transition
Q1
FY 2025
Q2
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
S-8 POS